1. Home
  2. CDT vs FGI Comparison

CDT vs FGI Comparison

Compare CDT & FGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • FGI
  • Stock Information
  • Founded
  • CDT 2019
  • FGI 1987
  • Country
  • CDT United States
  • FGI United States
  • Employees
  • CDT N/A
  • FGI N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • FGI Industrial Specialties
  • Sector
  • CDT Health Care
  • FGI Industrials
  • Exchange
  • CDT Nasdaq
  • FGI Nasdaq
  • Market Cap
  • CDT 5.3M
  • FGI 5.1M
  • IPO Year
  • CDT N/A
  • FGI 2022
  • Fundamental
  • Price
  • CDT $0.40
  • FGI $0.77
  • Analyst Decision
  • CDT
  • FGI
  • Analyst Count
  • CDT 0
  • FGI 0
  • Target Price
  • CDT N/A
  • FGI N/A
  • AVG Volume (30 Days)
  • CDT 3.1M
  • FGI 237.7K
  • Earning Date
  • CDT 05-20-2025
  • FGI 05-20-2025
  • Dividend Yield
  • CDT N/A
  • FGI N/A
  • EPS Growth
  • CDT N/A
  • FGI N/A
  • EPS
  • CDT N/A
  • FGI N/A
  • Revenue
  • CDT N/A
  • FGI $131,818,073.00
  • Revenue This Year
  • CDT N/A
  • FGI $8.04
  • Revenue Next Year
  • CDT N/A
  • FGI $6.41
  • P/E Ratio
  • CDT N/A
  • FGI N/A
  • Revenue Growth
  • CDT N/A
  • FGI 12.43
  • 52 Week Low
  • CDT $0.51
  • FGI $0.46
  • 52 Week High
  • CDT $350.00
  • FGI $1.36
  • Technical
  • Relative Strength Index (RSI)
  • CDT 31.06
  • FGI 67.22
  • Support Level
  • CDT $0.37
  • FGI $0.50
  • Resistance Level
  • CDT $0.57
  • FGI $0.59
  • Average True Range (ATR)
  • CDT 0.05
  • FGI 0.05
  • MACD
  • CDT 0.01
  • FGI 0.03
  • Stochastic Oscillator
  • CDT 13.89
  • FGI 86.84

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About FGI FGI Industries Ltd.

FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.

Share on Social Networks: